About me

Dr. Cristina García de la Mària is a researcher at IDIBAPS and has been the coordinator of the Experimental Endocarditis Laboratory for the last eighteen years. Together with the rest of the experimental endocarditis laboratory team, she conducts and carries out the in vitro and in vivo studies of the different models described in the group's lines of research. It is also responsible for the direction and training in the laboratory of master's and predoctoral students as well as researchers on postdoctoral stays. She has published 68 articles in peer review journals and coordinates the Work in Progress and Journal Club weekly sessions of the Endocarditis Team.

Featured publications

Featured Projects

  • Prevention of vascular catheter-related infections by the FUNctionalization of CATHeters with thermically activated hydrogels with antimicrobial agents of broad spectrum (FUNCATH).

    Principal investigator: Cristina Garcia de la Maria
    Funder: Fundació La Marató de TV3
    Code: 75/C/2018
    Duration: 15/01/2019 - 31/12/2022
  • In vitro and experimental endocarditis model study of the efficacy of new oral and parenteral combinations of antibiotics for outpatient treatment of infectious endocarditis

    Principal investigator: José Maria Miró Meda
    Funder: ISCIII (Participante)
    Code: PI 20/00830
    Duration: 01/01/2021
  • Staphylococcus aureus sensitivity to CF-301 Lysin in an in vitro study by Broth Microdilution Method.

    Principal investigator: Josep M. Miró Meda
    Funder: ContraFect Corporation
    Duration: 01/03/2019
  • Estudio de la eficacia de daptomicina asociada a otros antibióticos en el tratamiento de la endocarditis experimental por Staphylococcus aureus resistente o no a meticilina (SARM/SASM) y Staphylococcus epidermidis resistentes a meticilina (SERM) y a vancomicina (VRSE)

    Principal investigator: Jose Maria Miro Meda
    Funder: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Instituto de Salud Carlos III
    Duration: 01/01/2011 - 31/12/2013
  • To evaluate wether the combination of gentamicin and daptomycin (at doses of 6 mg/ kg or 10 mg/Kg) prevents the development of daptomycin resistance in the treatment of experimental endocarditis in rabbits infected with a penicillin-resistant Streptococcus mitis strain that develops a high level of daptomycin resistance when daptomycin is given in monotherapy.

    Principal investigator: Jose Maria Miro Meda
    Funder: Cubist Pharmaceutical ; Fundació Privada Clínic per a la Recerca Biomèdica (Participante)
    Duration: 01/01/2011